{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:07:12Z","timestamp":1790370432611,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13311-022-01239-2","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T13:23:32Z","timestamp":1652102612000},"page":"1329-1339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A"],"prefix":"10.1016","volume":"19","author":[{"given":"Austin W.","family":"Nenninger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Willman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Willman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mesidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole K","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Joly-Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-1832","authenticated-orcid":false,"given":"Kevin R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-022-01239-2_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: a review of the clinical and genetic aspects","volume":"40","author":"Clayton-Smith","year":"2003","journal-title":"J Med Genet"},{"issue":"1","key":"10.1007\/s13311-022-01239-2_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/302473","article-title":"Genetics of Angelman syndrome","volume":"65","author":"Jiang","year":"1999","journal-title":"The American Journal of Human Genetics"},{"key":"10.1007\/s13311-022-01239-2_bib3","doi-asserted-by":"crossref","unstructured":"Dagli, A., Buiting, K., and Williams, C.A., Molecular and Clinical Aspects of Angelman Syndrome. Mol Syndromol, 2012. 2(3-5): p. 100-112.15.","DOI":"10.1159\/000328837"},{"key":"10.1007\/s13311-022-01239-2_bib4","unstructured":"Jiang W, et al. Analysis of clinical phenotype and genetic variants in a Chinese pedigree affected with Angelman syndrome. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin J Med Genet. 2021;38(8):723\u201326."},{"issue":"7","key":"10.1007\/s13311-022-01239-2_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/genes12070987","article-title":"Genotype\u2013phenotype correlations in Angelman syndrome","volume":"12","author":"Yang","year":"2021","journal-title":"Genes"},{"key":"10.1007\/s13311-022-01239-2_bib6","unstructured":"U.S. Food and Drug Administration, C.f.B.E.a.R., ZOLGENSMA BLA 125694\/0 Approval Letter. 2019."},{"key":"10.1007\/s13311-022-01239-2_bib7","unstructured":"U.S. Food and Drug Administration, C.f.B.E.a.R., LUXTURNA BLA 125610\/0 Approval Letter. 2017."},{"issue":"12","key":"10.1007\/s13311-022-01239-2_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027221","article-title":"Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome","volume":"6","author":"Daily","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01239-2_bib9","doi-asserted-by":"crossref","unstructured":"Born HA, et al. Early developmental EEG and seizure phenotypes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome. eneuro. 2021;8(2):p. ENEURO.0345\u201320.","DOI":"10.1523\/ENEURO.0345-20.2020"},{"key":"10.1007\/s13311-022-01239-2_bib10","doi-asserted-by":"crossref","unstructured":"Berg EL, et al. Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome. Translat Psychiat. 2020;10(1).","DOI":"10.1038\/s41398-020-0720-2"},{"issue":"3","key":"10.1007\/s13311-022-01239-2_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/aur.2267","article-title":"Generation of a novel rat model of Angelman syndrome with a complete Ube3a gene deletion","volume":"13","author":"Dodge","year":"2020","journal-title":"Autism Res"},{"issue":"4","key":"10.1007\/s13311-022-01239-2_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/aur.2475","article-title":"Identification of UBE3A Protein in CSF and Extracellular Space of the Hippocampus Suggest a Potential Novel Function in Synaptic Plasticity","volume":"14","author":"Dodge","year":"2021","journal-title":"Autism Res"},{"issue":"4","key":"10.1007\/s13311-022-01239-2_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","article-title":"Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation","volume":"21","author":"Jiang","year":"1998","journal-title":"Neuron"},{"key":"10.1007\/s13311-022-01239-2_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4939-3271-9_7","article-title":"Small-scale recombinant adeno-associated virus purification","volume":"1382","author":"Burger","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-022-01239-2_bib15","doi-asserted-by":"crossref","unstructured":"Nash, K.R. and Gordon, M.N., Convection Enhanced Delivery of Recombinant Adeno-associated Virus into the Mouse Brain. Methods Mol Biol, 2016. 1382: p. 285-95.","DOI":"10.1007\/978-1-4939-3271-9_21"},{"issue":"1","key":"10.1007\/s13311-022-01239-2_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneumeth.2010.10.010","article-title":"Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain","volume":"194","author":"Carty","year":"2010","journal-title":"J Neurosci Methods"},{"issue":"7","key":"10.1007\/s13311-022-01239-2_bib17","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1523\/JNEUROSCI.23-07-02634.2003","article-title":"Derangements of hippocampal calcium\/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome","volume":"23","author":"Weeber","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1007\/s13311-022-01239-2_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059626","article-title":"Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice","volume":"8","author":"Carty","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1007\/s13311-022-01239-2_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1460-9568.2012.07993.x","article-title":"Hippocampal CA3 and CA2 have distinct bilateral innervation patterns to CA1 in rodents","volume":"35","author":"Shinohara","year":"2012","journal-title":"Eur J Neurosci"},{"issue":"8","key":"10.1007\/s13311-022-01239-2_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104829","article-title":"Retrograde axonal transport property of adeno-associated virus and its possible application in future","volume":"23","author":"Wang","year":"2021","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1007\/s13311-022-01239-2_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/gt.2016.24","article-title":"Axonal transport of AAV9 in nonhuman primate brain","volume":"23","author":"Green","year":"2016","journal-title":"Gene Ther"},{"issue":"3","key":"10.1007\/s13311-022-01239-2_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mt.2013.237","article-title":"Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment","volume":"22","author":"Castle","year":"2014","journal-title":"Mol Ther"},{"issue":"8","key":"10.1007\/s13311-022-01239-2_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/hum.2013.189","article-title":"Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport","volume":"25","author":"Castle","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1007\/s13311-022-01239-2_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1227\/NEU.0000000000000157","article-title":"Comparison of endovascular and intraventricular gene therapy with adeno-associated virus\u2013\u03b1-L-iduronidase for Hurler disease","volume":"74","author":"Janson","year":"2014","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1007\/s13311-022-01239-2_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01239-2_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.618360","article-title":"Comparative effectiveness of intracerebroventricular, intrathecal, and intranasal routes of AAV9 vector administration for genetic therapy of neurologic disease in murine mucopolysaccharidosis type I","volume":"14","author":"Belur","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1007\/s13311-022-01239-2_bib27","first-page":"624","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"issue":"5","key":"10.1007\/s13311-022-01239-2_bib28","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1172\/JCI80554","article-title":"Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model","volume":"125","author":"Silva-Santos","year":"2015","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1007\/s13311-022-01239-2_bib29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/hmg\/ddab104","article-title":"Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells","volume":"30","author":"Adhikari","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-022-01239-2_bib30","doi-asserted-by":"crossref","unstructured":"Dodge A, et al. Identification of UBE3A protein in CSF and extracellular space of the hippocampus suggest a potential novel function in synaptic plasticity. Autism Res, Online ahead of print. 2021.","DOI":"10.1002\/aur.2475"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01239-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01239-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01239-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:48:20Z","timestamp":1761806900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1878747923010863"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01239-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01239-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}